PF
PLX icon

Phoenix Financial’s Protalix BioTherapeutics PLX Stock Holding History

Phoenix Financial’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.7K Buy
+40,000
New +$99.3K ﹤0.01% 479
2022
Q2 		– Sell
-244,113
Closed -$259K – 416
2022
Q1 		$259K Hold
244,113
– – ﹤0.01% 349
2021
Q4 		$203K Hold
244,113
– – ﹤0.01% 365
2021
Q3 		$325K Hold
244,113
– – 0.01% 356
2021
Q2 		$466K Hold
244,113
– – 0.01% 276
2021
Q1 		$1.09M Buy
+244,113
New +$1.14M 0.02% 276
2020
Q4 		– Sell
-204,355
Closed -$751K – 415
2020
Q3 		$751K Buy
204,355
+16,019
+9% +$57.9K 0.03% 216
2020
Q2 		$681K Buy
+188,336
New +$644K 0.03% 226

Other funds holding PLX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $604M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.21B AUM 26.82% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return